Ledger.Open graph →
SEC Form D · filed August 7, 2023

Gossamer Bio, Inc

Offering
$212.1M
Sold
$212.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Sandra Milligan, M.D., J.D · San Diego, CADirectorRichard Aranda, M.D · San Diego, CAExecFaheem Hasnain · San Diego, CAExec · DirectorThomas Daniel, M.D · San Diego, CADirectorRussell Cox · San Diego, CADirectorCaryn Peterson · San Diego, CAExecChristian Waage · San Diego, CAExecBryan Giraudo · San Diego, CAExecRenee Gala · San Diego, CADirectorKristina Burow · San Diego, CADirectorJeffrey Cohen · Los Angeles, CADirectorSean Wagner · New York, NYExecAli Hamed · New York, NYDirectorChristopher Brady · New York, NYDirectorRichard L. Carrion · San Juan, Puerto RicoExecNicholas Tommarello · SAN FRANCISCO, CAExecNeil Doshi · Orange, CAExec · DirectorKhaled El-Marsafy · New York, NYDirectorAmi Doshi · Orange, CAExecPeter Head · London, United KingdomDirectorJudy Reiner · San Luis Obispo, CADirectorDaniel Woodford · WASHINGTON, Washington, D.C.DirectorJames T. Mcclements · Denver, COExecMason G. Hills · Denver, COExec · DirectorMichele G. Valenti · Denver, CODirectorRussell L. Cranswick · Denver, CODirectorLyle J. Bruce · Denver, COExecRoss R. Bhappu · Denver, CODirectorDavid J. Halkyard · Denver, COExecFilipp Chebotarev · Bellingham, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗